期刊文献+

人β-防御素3融合细菌膜穿透增加蛋白在毕赤酵母中的表达 被引量:9

Fusion expression of human β-defensin 3 and bactericidal/permeability increasing protein in P. pastoris
下载PDF
导出
摘要 目的:探讨采用酵母表达系统进行人β-防御素3(hBD3)与细菌膜穿透增加蛋白(BPI)融合表达的可行性.方法:将hBD3成熟肽基因通过Linker蛋白与BPI基因串联,克隆于酵母表达载体pPICZαB中,电转导入X-33毕赤酵母菌,经重组酵母基因组PCR和表型鉴定获得阳性克隆,对阳性克隆进行甲醇诱导表达,上清进行目的蛋白纯化和Western Blot鉴定.结果:重组载体经酶切和测序证实序列正确,重组X-33-pICZαB-hBD3-BPI克隆经甲醇诱导24h后,上清SDS-PAGE电泳显示有目的蛋白表达,Western Blot分析表明重组蛋白抗人hBD3和BPI均阳性,该目的蛋白依次通过疏水色谱、离子交换色谱纯化,蛋白纯度达到89%.结论:采用毕赤酵母系统融合表达hBD3和BPI是可行的. AIM: To investigate the possibility of fusion expression of human β-defensin 3 (hBD3) and bactericidal/permeability increasing protein (BPI) in P. pastoris. METHODS: DNA fragments encoding hBD3 mature peptide and BPI were linked via a Linker sequence and cloned into yeast expression vector pPICZαB followed by introduction into P. pastor/s-X-33 by electrical transduction. Positive clones identified by genomic PCR and phenotype analysis were induced by methanol for protein expression. In supernatants, recombinant protein was purified by phenyl sepharose high performance and source 30Q ion-exchange columns. Western Blot against hBD3 and BPI was performed respectively to identify the recombinant protein. RESULTS: Recombinant pICZαB-hBD3-BPI was proved correct by restriction analysis and sequencing. X-33-pICZαB-hBD3-BPI clone expressed the recombinant fusion protein in SDS-PAGE electrophoresis after in- duction for 24 h. The protein product was both hBD3- and BPI- positive. A purity of 89% was reached after purification procedures. CONCLUSION: It's feasible to express hBD3 fused to BPI in P. pastoris yeast expression system.
出处 《第四军医大学学报》 北大核心 2007年第7期648-650,共3页 Journal of the Fourth Military Medical University
关键词 人β-防御素3 细菌膜穿透增加蛋白 融合表达 毕赤酵母 human β-defensin 3 bactericidal/permeability increasing protein fusion expression P. pastoris yeast
  • 相关文献

参考文献9

  • 1von Bubnoff A.Seeking new antibiotic in nature's backyard[J].Cell,2006,127(5):867-869.
  • 2Jenssen H,Hamill P,Hancock REW.Peptide antimicrobial agents[J].Clin Microbiol Rev,2006,19(3):491-511.
  • 3Radtke AL,O'Riordan MX.Intracellular innate resistance to bacterial pathogens[J].Cell Microbiol,2006,8(11):1720-1729.
  • 4Pereira HA.Novel therapies based on cationic antimicrobial peptides[J].Curr Pharm Biotechnol,2006,7(4):229-234.
  • 5Pazgiera M,Hooverb DM,Yangc D,et al.Human β-defensins[J].Cell Mol Life Sci,2006,63(11):1294-1313.
  • 6Klotman ME,Chang TL.Defensins in innate antiviral immunity[J].Nat Rev Immunol,2006,6(6):447-456.
  • 7Feng Z,Dubyak GR,Lederman MM,et al.Cutting edge:Human beta-defensin 3-a novel antagonist of the HIV-1 coreceptor CXCR4[J].J Immunol,2006,177(2):782-786.
  • 8庹晓晔,徐明达.人β-防御素-3基因的克隆和序列测定[J].第四军医大学学报,2002,23(8):701-703. 被引量:7
  • 9Chen H,Xu Z,Peng L,et al.Recent advances in the research and development of human defensins[J].Peptides,2006,27(4):931-940.

共引文献6

同被引文献119

引证文献9

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部